452 filings
Page 10 of 23
6-K
CLLS
Cellectis
16 Feb 21
Cytovia Therapeutics and Cellectis Partner to Develop TALENĀ® Gene-Edited iPSC-Derived Natural Killer Cells
6:10am
SC 13G/A
ARK Investment Management LLC
16 Feb 21
Cellectis / ARK Investment Management ownership change
12:00am
SC 13D/A
CLLS
Cellectis
12 Feb 21
Cellectis / Bpifrance Participations ownership change
2:09pm
SC 13G/A
CLLS
Cellectis
8 Feb 21
Cellectis / FMR ownership change
10:17am
CT ORDER
CLLS
Cellectis
29 Dec 20
Confidential treatment order
8:53am
6-K
CLLS
Cellectis
29 Dec 20
Current report (foreign)
7:48am
6-K
CLLS
Cellectis
16 Dec 20
Cellectis Announces Withdrawal of Follow-On Offering
3:00pm
424B5
CLLS
Cellectis
14 Dec 20
Prospectus supplement for primary offering
9:41pm
FWP
CLLS
Cellectis
14 Dec 20
Free writing prospectus
5:12pm
6-K
CLLS
Cellectis
14 Dec 20
Cellectis Announces Launch of Follow-On Offering
4:30pm
6-K
CLLS
Cellectis
7 Dec 20
Current report (foreign)
6:06am
6-K
CLLS
Cellectis
18 Nov 20
Current report (foreign)
6:00am
6-K
CLLS
Cellectis
16 Nov 20
Cellectis Appoints Pharma HR Leader Kyung Nam-Wortman as Executive Vice President, Chief Human Resources Officer
4:30pm
SC 13G
ARK Investment Management LLC
10 Nov 20
Cellectis / ARK Investment Management ownership change
2:48pm
6-K
CLLS
Cellectis
5 Nov 20
Current report (foreign)
4:46pm
6-K
CLLS
Cellectis
5 Nov 20
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2020
4:44pm
6-K
CLLS
Cellectis
5 Nov 20
Current report (foreign)
4:18pm
6-K
CLLS
Cellectis
4 Nov 20
Current report (foreign)
9:25am
SC 13D/A
CBUS
Cibus Inc - Ordinary Shares
23 Oct 20
Calyxt / Cellectis ownership change
4:01pm
4
CBUS
Cibus Inc - Ordinary Shares
20 Oct 20
Change in insider ownership
6:05am